VOLITIONRX LTD — Director's Dealing 2016

Apr 22, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2016-04-20

Reporting Person: Reynolds Cameron John (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-04-20	Common Stock	X	1172	$2.6	Acquired	1103844	Direct
2016-04-20	Common Stock	X	1429	$2.6	Acquired	28287	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-04-20	Warrant (Right to Buy)	$2.6	X	1172	Disposed	2016-05-10	Common Stock (1172)	Direct
2016-04-20	Warrant (Right to Buy)	$2.6	X	1429	Disposed	2016-05-10	Common Stock (1429)	Indirect